We would be really grateful if you could spend 1 min of your time to complete this quick survey for the use of ADJUVANT Bisphosphonates in Early Breast Cancer.
Please click on the following link to complete the survey: https://www.surveymonkey.co.uk/r/N7BX5BR
Adjuvant Bisphosphonates are now standard of care in Early Breast Cancer and our aim, through this pharmacists’ survey, is to confirm their use in the UK.
It’s awards time – call for nominations! We have had lots of positive feedback from the introduction of the awards dinner at the annual conference, and we are now calling…
We are pleased to share that a new national forum for oncology and haematology clinical trials pharmacy is now live for BOPA members. As many of you know, working in…
NCODA is proud to introduce a new resource designed to help make cancer treatment more manageable for all involved. NCODA Patient Treatment Calendars give patients and caregivers a clear, practical…
Non-promotional post on behalf of Gilead Sciences Ltd. The Gilead UK & Ireland Oncology Fellowship and Medical Grants Programme accepts applications for any project that supports innovation and best practice…
The 29th BOPA Annual Conference in 2026 will be held at the ICC London Olympia on 2-4 October 2026.
Check out the latest information here: Latest Conference 2026 – BOPA
Everything you need to know
